M&A Deal Summary |
|
|---|---|
| Date | 2023-06-27 |
| Target | Spiegelberg |
| Sector | Medical Products |
| Buyer(s) | Luciole Medical |
| Sellers(s) | SHS Capital |
| Deal Type | Add-on Acquisition |
SEARCH BY
Luciole Medical is developing a unique next-generation platform of brain monitoring sensors to rapidly provide important information allowing the proper diagnostic and monitoring of compromised oxygen supply conditions and complications. Luciole Medical is based in Zurich, Switzerland.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| Country: Germany M&A | 1 of 1 |
| Year: 2023 M&A | 1 of 1 |
SHS Capital is a private equity firm focused on the healthcare sector. Specific areas of interest include life science, medical technology, diagnostics, applied technologies, digital health, and industrial biotechnology. The Firm will consider opportunities at all company stages and looks to commit up to €50 million in businesses valued up to €150 million. Target geographies include Germany, Austria, Switzerland, Scandinavia, and Benelux. SHS Capital was established in 1993 and is headquartered in Tubingen, Germany.
| DEAL STATS | # |
|---|---|
| Overall | 14 of 17 |
| Sector: Medical Products M&A | 5 of 6 |
| Type: Add-on Acquisition M&A Deals | 9 of 10 |
| Country: Germany M&A | 11 of 13 |
| Year: 2023 M&A | 1 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-06-22 |
MESI
Ljubljana, Slovenia MESI is an innovative company committed to digitalizing healthcare at primary level and beyond. Its core product, the MESI mTABLET, enabled them to introduce a new diagnostic category: predictive medical assessment. This is a combination of digital diagnostic measurements, immediate storage and availability of patient records, clinical support tools, and clinical AI recommendations on one device. MESI was founded in 2010 and is based in Ljubljana, Slovenia. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-07-07 |
CAM Bioceramics
Leiden, Netherlands CAM Bioceramics is a contract development and manufacturing organization of orthobiologic calcium phosphates (CaP) and calcium hydroxy appetite (CaHa) with a focus on MedTech and Life Science applications. CAM Bioceramics was founded in 1985 and is headquartered in Leiden, Netherlands. |
Buy | - |